Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.65 |
| ▸ | CCR3 | P51677 | 2/20 | 0.59 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.53 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.53 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.53 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.52 |
| ▸ | MGLL | Q99685 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6290794 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL113380 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL28374076 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL1119456 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL29013918 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL158625 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL8137977 | 0.98 | GBA1 (0.63) | GBA1CCR3SLC18A3POLBPRMT3 | |
| Ammonia Solution, Strong SCHEMBL2283846 | 0.95 | GBA1 (0.61) | GBA1CCR3SLC18A3POLBPRMT3 | |
| SCHEMBL8701 | 0.95 | GBA1 (0.65) | GBA1CCR3SLC18A3PRMT3CARM1 | |
| Hydrochloric Acid SCHEMBL28647348 | 0.93 | GBA1 (0.63) | GBA1CCR3SLC18A3PRMT3CARM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059937-A | Compound containing thick furan and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122059980-A | Compound containing bistriazine structure and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122059981-A | Fluorene compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2025132776-A1 | USE OF IRON-BASED COMPOUNDS FOR THE SYNTHESIS OF BORATED COMPOUNDS, AND CORRESPONDING METHODS | Universite Paris-Saclay (FR) | 2025-06-26 | — | — | WO | claimed |
| CN-120081834-A | Heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120076569-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120025314-A | Carbazole compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119874691-A | Heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119638686-A | Nitrogen-containing heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119552174-A | TLR7 and TLR8 inhibitors, methods of making, pharmaceutical compositions and uses thereof | 上海深势唯思科技有限责任公司 | 2025-03-04 | — | — | CN | claimed |
| US-20020156102-A1 | Piperidine amides as modulators of chemo kine receptor activity | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-10-24 | — | — | US | claimed |
| US-6376548-B1 | FUNGICIDES; HERBICIDES; INSECTICIDES | ROHM AND HAAS COMPANY | 2002-04-23 | — | — | US | claimed |
| WO-2001098268-A2 | PIPERIDINE AMIDES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-12-27 | — | — | WO | claimed |
| WO-2001098269-A2 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-12-27 | — | — | WO | claimed |
| EP-0680469-B1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | BOEHRINGER INGELHEIM PHARMA (DE) | 2000-04-26 | — | — | EP | claimed |
| US-5658943-A | VASODILATOR FOR CARDIOVASCULAR DISORDER, HYPOTENSIVE AGENT | WARNER-LAMBERT COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-5234942-A | Treating allergic pulmonary disorders, asthma | ICI AMERICAS INC. (US) | 1993-08-10 | — | — | US | claimed |
| US-4997844-A | Compounds for the treatment of allergic or inflammatory diseases or shock conditions | ICI AMERICAS INC. (US) | 1991-03-05 | — | — | US | claimed |
| EP-0179619-B1 | HETEROCYCLIC AMIDES | ICI AMERICAS INC. (US) | 1990-09-05 | — | — | EP | claimed |
| US-4061746-A | Lactamimide inhibitors of gastrointestinal hypersecretion | RICHARDSON-MERRELL INC. (US) | 1977-12-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156102-A1 | Piperidine amides as modulators of chemo kine receptor activity | CCR3, CCR1, ACKR3 | GBA1 3587/4885CCR3 1/4885SLC18A3 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.